GEN Exclusives

More »
New Products

Related to MDxHealth and NovioGendix Win $1.1M Grant to Develop Bladder Cancer Diagnostic

    • Protein Biomarker Immunoassays
    • Olink Bioscience
    • Proseek® Multiplex is a generation of multiplexed protein biomarker immunoassays based on the Proximity Extension Assay (PEA) platform. Proseek Multiplex allows biomarker researchers to quantify 92 proteins in one microliter sample against a p
    • Assays for Stem Cell Protein Markers
    • EMD Millipore
    • The Milliplex® MAP human stem cell pluripotency magnetic bead kits enable the analysis of many different pluripotency biomarkers in a single measurement. The kits examine protein biomarkers that indicate the potency of stem cells, enabling plu
    • Microarray Scanner
    • Agilent Technologies
    • The SureScan Dx microarray scanner is indicated for use in a clinical laboratory environment when measuring fluorescence signals of labeled DNA or RNA targets hybridized to microarrays used as part of a validated diagnostic assay. The system has be
    • Kits for Analyzing Modified Cytosines
    • Cambridge Epigenetix
    • TrueMethyl™ kits provide quantitative, accurate and repeatable single-base resolution sequencing of the modified bases hydroxymethylcytosine (5-hmC) and methylcytosine (5-mC) in genomic DNA. This capability is attributable to the kits’ utiliza
    • DNA Reference Standard
    • Horizon Discovery
    • The Quantitative Multiplex DNA reference standard is intended for researchers assessing multiple biomarkers in a single assay using platforms such as next-generation sequencing. It can enable researchers to quantify a range of detection thresholds
  • Page 1 of 1 (5 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?